Biomet Sold, to Stay in Warsaw

A sale of orthopedic company Biomet will apparently keep the company’s headquarters in Warsaw, along with more than 13-hundred jobs. Biomet’s board of directors has accepted an offer from a private equity group worth nearly 11-billion dollars. The deal still requires the approval of stockholders and federal regulators. Biomet Interim President Dan Hann says if the purchase takes place, it probably won’t affect Biomet’s day-to-day operations. The deal would pay stockholders 44 dollars a share and take the company off the stock market.